Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
AMD
Absci partners with semiconductor company AMD for AI drug discovery
By
Anthony Vecchione
|
01:37 pm |
January 21, 2025
AMD is making a $20 million equity investment to bolster Absci's drug discovery efforts and expand AMDs accelerators and ROCm software.